Why It’s Important: The U.S. Department of Defense (DOD) has recently sought to diversify its approach to securing advanced microprocessors by leveraging commercially available technologies developed by U.S. companies. Other than Intel, the majority of U.S.-based chip designers are fabless, which means they design and sell integrated circuits that are fabricated by contract manufacturers called foundries. Today, more than 80 percent of leading-edge manufacturing capacity is concentrated in Asia1, leaving the DOD with limited onshore access to foundry technology capable of meeting the country’s long-term needs for secure microelectronics. The RAMP-C program was created to facilitate the use of a commercially viable onshore foundry ecosystem that will ensure DOD access to leading-edge technology, while allowing the defense industrial base to leverage the benefits of high-volume semiconductor manufacturing and design infrastructure of commercial partners like Intel.
---
yep - these will be the foundries of choice due to secure logistic chain. Given BRN are licensing IP, and the military/aerospace has been highlighted as a target industry we are engaged with, it's only common sense that this secure foundry logistic chain is a destination for producing our neuromorphic IP.
its as common sense as putting edge processors on UAVs
- Forums
- ASX - By Stock
- BRN
- 2021 BRN Discussion
2021 BRN Discussion, page-27920
-
- There are more pages in this discussion • 5,661 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BRN (ASX) to my watchlist
(20min delay)
|
|||||
Last
19.8¢ |
Change
-0.003(1.25%) |
Mkt cap ! $366.5M |
Open | High | Low | Value | Volume |
20.0¢ | 20.5¢ | 19.5¢ | $795.0K | 3.944M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
83 | 1487737 | 19.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.0¢ | 717191 | 33 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
86 | 1488848 | 0.195 |
62 | 1643521 | 0.190 |
32 | 1783131 | 0.185 |
54 | 1593743 | 0.180 |
17 | 632162 | 0.175 |
Price($) | Vol. | No. |
---|---|---|
0.200 | 798493 | 35 |
0.205 | 1014912 | 20 |
0.210 | 1428077 | 26 |
0.215 | 536730 | 24 |
0.220 | 758461 | 24 |
Last trade - 15.51pm 15/07/2024 (20 minute delay) ? |
Featured News
BRN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online